BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10321985)

  • 1. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
    Chen Z; Li K; Rowland RR; Plagemann PG
    J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.
    Chen Z; Li K; Rowland RR; Anderson GW; Plagemann PG
    J Neurovirol; 1998 Oct; 4(5):560-8. PubMed ID: 9839654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
    Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
    J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
    Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
    Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
    Plagemann PG; Chen Z; Li K
    Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
    Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
    J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus.
    Harty JT; Plagemann PG
    J Virol; 1990 Dec; 64(12):6257-62. PubMed ID: 2243393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
    Harty JT; Chan SP; Contag CH; Plagemann PG
    J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus.
    Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
    J Virol; 1995 Jan; 69(1):308-19. PubMed ID: 7983723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons.
    Contag CH; Plagemann PG
    J Virol; 1989 Oct; 63(10):4362-9. PubMed ID: 2550670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency homologous genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants.
    Li K; Chen Z; Plagemann P
    Virology; 1999 May; 258(1):73-83. PubMed ID: 10329569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization.
    Li K; Schuler T; Chen Z; Glass GE; Childs JE; Plagemann PG
    Virus Res; 2000 Apr; 67(2):153-62. PubMed ID: 10867194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase-elevating virus correlates with increased expression of endogenous retrovirus in motor neurons.
    Contag CH; Plagemann PG
    Microb Pathog; 1988 Oct; 5(4):287-96. PubMed ID: 3237056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathogenicity and susceptibility to immune response are interdependent properties of lactate dehydrogenase-elevating virus (LDV) and correlate with the number of N-linked polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein.
    Chen Z; Li K; Rowland RR; Plagemann PG
    Adv Exp Med Biol; 1998; 440():583-92. PubMed ID: 9782333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro.
    Inada T; Yamazaki S
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2437-44. PubMed ID: 1655956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of virus-induced age-dependent poliomyelitis by interferon-gamma.
    Cafruny WA; Haven TR; Lawson SR; Wong GH; Rowland RR
    Antiviral Res; 1997 Sep; 36(1):1-9. PubMed ID: 9330756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.